Lipid nanoparticles for cancer therapy: state of the art and future prospects

Bibliography

• WHO: Cancer. 2012. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/ [Last accessed 15 May 2012]
   Google Scholar
• Bhosle J, Hall G. Principles of cancer treatment by chemotherapy. Surgery 2009;27:173-7
   Google Scholar
• Principe P, Braquet P. Advances in ether phospholipids treatment of cancer. Crit Rev Oncol 1995;18:155-78
   PubMed Web of Science ®Google Scholar
• Banna GL, Collovà E, Gebbia V, Anticancer oral therapy: emerging related issues. Cancer Treat Rev 2010;36:595-605
   PubMed Web of Science ®Google Scholar
• Estella-Hermoso de Mendoza A, Campanero MA, Mollinedo F, Lipid nanomedicines for anticancer drug therapy. J Biomed Nanotechnol 2009;5:323-43
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751-60
   PubMed Web of Science ®Google Scholar
• Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 2011;63:131-5
   PubMed Web of Science ®Google Scholar
• Paliwal R, Rai S, Vaidya B, Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine 2009;5:184-91
   PubMed Web of Science ®Google Scholar
• Estella-Hermoso de Mendoza A, Campanero MA, Lana H, Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles. Nanomedicine 2012;7:679-90
   PubMed Web of Science ®Google Scholar
• Estella-Hermoso de Mendoza A, Preat V, Mollinedo F, In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma. J Control Release 2011156:421-6
   PubMed Web of Science ®Google Scholar
• Altmayer P, Grundmann U, Ziehmer M, Comparative effectiveness and tolerance study of a new galenic etomidate formula. Anasthesiol Intensivmed Notfallmed Schmerzther 1993;28:415-19
   PubMedGoogle Scholar
• Müller RH, Petersen RD, Hommoss A, Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 2007;59:522-30
   PubMed Web of Science ®Google Scholar
• Allen TM. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol Sci 1994;15:215-20
   PubMed Web of Science ®Google Scholar
• Speiser P. Lipid nanopellets als tragersystem fur arzneimittel zur peroralen anwendung. EP0167825; 1990
   Google Scholar
• Eldem T, Speiser P, Hincal A. Optimization of spray-dried and -congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm Res 1991;8:47-54
   PubMed Web of Science ®Google Scholar
• Schwarz C, Mehnert W, Lucks JS, Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release 1994;30:83-96
   Web of Science ®Google Scholar
• Müller RH, Lucks JS. Medication vehicles made of solid lipid particles (solid lipid nanospheres - SLN). EP0605497; 1993
   Google Scholar
• Gasco MR. Solid lipid nanospheres from warm microemulsions. Pharm Tech Eur 1997;9:52-8
   Google Scholar
• Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. US188837; 1993
   Google Scholar
• Cai S, Yang Q, Bagby TR, Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Adv Drug Deliv Rev 2011;63:901-908
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002;242:121-8
   PubMed Web of Science ®Google Scholar
• Liu D, Liu Z, Wang L, Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B Biointerfaces 2011;85:262-9
   PubMed Web of Science ®Google Scholar
• Sharma P, Dube B, Sawant K. Development and evaluation of nanostructured lipid carriers of cytarabine for treatment of meningeal leukemia. J Nanosci Nanotechnol 2011;11:6676-82
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhao Y, Geng L, Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:3721-7
   PubMed Web of Science ®Google Scholar
• Li F, Weng Y, Wang L, The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers. Int J Pharm 2010;393:203-11
   PubMed Web of Science ®Google Scholar
• Zhang XG, Miao J, Dai YQ, Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells. Int J Pharm 2008;361:239-44
   PubMed Web of Science ®Google Scholar
• Müller RH, Olbrich C. Lipid matrix-drug conjugates particle for controlled release of active ingredients. US6770299; 2002
   Google Scholar
• Muchow M, Maincent P, Müller RH. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm 2008;34:1394-405
   PubMed Web of Science ®Google Scholar
• üMller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54(Suppl 1):S131-55
   PubMedGoogle Scholar
• Avestin. Available from: www.avestin.com [Last accessed 15 May 2012]
   Google Scholar
• APV®. Available from: www.apv.com [Last accessed 15 May 2012]
   Google Scholar
• Mader K. Solid lipid nanoparticles as drug carriers. In: Torchilin V, editor. Nanoparticulates as drug carriers. Imperial College Press; London, UK 2006
   Google Scholar
• Charman WN, Stella VJ. Lymphatic transport of drugs. CRC Press; Boca Raton, Florida 1992
   Google Scholar
• Zimmermann E, Müller RH, Mader K. Influence of different parameters on reconstitution of lyophilized SLN. Int J Pharm 2000;196:211-13
   PubMed Web of Science ®Google Scholar
• Brown SC, Palazuelos M, Sharma P, Nanoparticle characterization for cancer nanotechnology and other biological applications. Methods Mol Biol 2010;624:39-65
   PubMedGoogle Scholar
• Estella-Hermoso de Mendoza A, Rayo M, Mollinedo F, Lipid nanoparticles for alkyl lysophospholipid edelfosine encapsulation: development and in vitro characterization. Eur J Pharm Biopharm 2008;68:207-13
   PubMed Web of Science ®Google Scholar
• Patel MR, San Martin-Gonzalez MF. Characterization of ergocalciferol loaded solid lipid nanoparticles. J Food Sci 2012;77:N8-13
   PubMed Web of Science ®Google Scholar
• Zaucha M, Adamczyk Z, Barbasz J. Zeta potential of particle bilayers on mica: a streaming potential study. J Colloid Interface Sci 2011;360:195-203
   PubMed Web of Science ®Google Scholar
• Thielbeer F, Donaldson K, Bradley M. Zeta potential mediated reaction monitoring on nano and microparticles. Bioconjug Chem 2011;22:144-50
   PubMed Web of Science ®Google Scholar
• Freire JM, Domingues MM, Matos J, Using zeta-potential measurements to quantify peptide partition to lipid membranes. Eur Biophys J 2011;40:481-7
   PubMed Web of Science ®Google Scholar
• Freitas C, Müller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles (SLN) dispersion. Int J Pharm 1998;168:221-9
   Web of Science ®Google Scholar
• Souto EB, Mehnert W, Müller RH. Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. J Microencapsul 2006;23:417-33
   PubMed Web of Science ®Google Scholar
• Bunjes H, Koch MH. Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles. J Control Release 2005;107:229-43
   PubMed Web of Science ®Google Scholar
• Bunjes H, Koch MH, Westesen K. Effect of surfactants on the crystallization and polymorphism of lipid nanoparticles. Prog Colloid Polym Sci 2002;121:7-10
   Google Scholar
• Bunjes H, Koch MH, Westesen K. Influence of emulsifiers on the crystallization of solid lipid nanoparticles. J Pharm Sci 2003;92:1509-20
   PubMed Web of Science ®Google Scholar
• Bunjes H, Steiniger F, Richter W. Visualizing the structure of triglyceride nanoparticles in different crystal modifications. Langmuir 2007;23:4005-11
   PubMed Web of Science ®Google Scholar
• Kramer T, Kremer DM, Pikal MJ, A procedure to optimize scale-up for the primary drying phase of lyophilization. J Pharm Sci 2009;98:307-18
   PubMed Web of Science ®Google Scholar
• Yadava P, Gibbs M, Castro C, Effect of lyophilization and freeze-thawing on the stability of siRNA-liposome complexes. AAPS Pharm Sci Tech 2008;9:335-41
   PubMed Web of Science ®Google Scholar
• Bensouda Y, Laatiris A. The lyophilization of dispersed systems: influence of freezing process, freezing time, freezing temperature and RBCs concentration on RBCs hemolysis. Drug Dev Ind Pharm 2006;32:941-5
   PubMed Web of Science ®Google Scholar
• Seetharam R, Wada Y, Ramachandran S, Long-term storage of bionanodevices by freezing and lyophilization. Lab Chip 2006;6:1239-42
   PubMed Web of Science ®Google Scholar
• Cavalli R, Caputo O, Gasco MR. Preparation and characterization of solid lipid nanospheres containing paclitaxel. Eur J Pharm Sci 2000;10:305-9
   PubMed Web of Science ®Google Scholar
• Souza LG, Silva EJ, Martins AL, Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Eur J Pharm Biopharm 2011;79:189-96
   PubMed Web of Science ®Google Scholar
• Subedi RK, Kang KW, Choi HK. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci 2009;37:508-13
   PubMed Web of Science ®Google Scholar
• del Pozo-Rodriguez A, Solinis MA, Gascon AR, Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm 2009;71:181-9
   PubMed Web of Science ®Google Scholar
• zur Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery–drug release and release mechanism. Eur J Pharm Biopharm 1998;45:149-55
   PubMed Web of Science ®Google Scholar
• Battaglia L, Gallarate M. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv 2012;9:497-508
   PubMed Web of Science ®Google Scholar
• Wu L, Tang C, Yin C. Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Drug Dev Ind Pharm 2010;36:439-48
   PubMed Web of Science ®Google Scholar
• Jain A, Agarwal A, Majumder S, Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. J Control Release 2010;148:359-67
   PubMed Web of Science ®Google Scholar
• Kuo YC, Liang CT. Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells. Colloids Surf B Biointerfaces 2011;85:131-7
   PubMed Web of Science ®Google Scholar
• Huang ZR, Hua SC, Yang YL, Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol Sin 2008;29:1094-102
   PubMed Web of Science ®Google Scholar
• Aji Alex MR, Chacko AJ, Jose S, Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci 2011;42:11-18
   PubMed Web of Science ®Google Scholar
• Dong X, Mattingly CA, Tseng MT, Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. Cancer Res 2009;69:3918-26
   PubMed Web of Science ®Google Scholar
• Xu Z, Chen L, Gu W, The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials 2009;30:226-32
   PubMed Web of Science ®Google Scholar
• Ying XY, Du YZ, Hong LH, Magnetic lipid nanoparticles loading doxorubicin for intracellular delivery: preparation and characteristics. J Magn Magn Mater 2011;323:1088-93
   Web of Science ®Google Scholar
• Mulik RS, Monkkonen J, Juvonen RO, Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm 2010;398:190-203
   PubMed Web of Science ®Google Scholar
• Yang X, Koh CG, Liu S, Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against bcl-2. Mol Pharm 2009;6:221-30
   PubMed Web of Science ®Google Scholar
• Gupta Y, Jain A, Jain SK. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol 2007;59:935-40
   PubMed Web of Science ®Google Scholar
• Jain SK, Chaurasiya A, Gupta Y, Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting. J Microencapsul 2008;25:289-97
   PubMed Web of Science ®Google Scholar
• Nimje N, Agarwal A, Saraogi GK, Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting. J Drug Target 2009;17:777-87
   PubMed Web of Science ®Google Scholar
• Mizrahy S, Raz SR, Hasgaard M, Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. J Control Release 2011;156:231-8
   PubMed Web of Science ®Google Scholar
• Rivkin I, Cohen K, Koffler J, Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors. Biomaterials 2010;31:7106-14
   PubMed Web of Science ®Google Scholar
• Scheibner KA, Lutz MA, Boodoo S, Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006;177:1272-81
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhong Z, Peng G, Folate receptor mediated intracellular gene delivery using the charge changing solid lipid nanoparticles. Drug Deliv 2009;16:341-7
   PubMed Web of Science ®Google Scholar
• Schroeder JE, Shweky I, Shmeeda H, Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles. J Control Release 2007;124:28-34
   PubMed Web of Science ®Google Scholar
• Goutayer M, Dufort S, Josserand V, Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. Eur J Pharm Biopharm 2010;75:137-47
   PubMed Web of Science ®Google Scholar
• Shimon-Hophy M, Wadhwani KC, Chandrasekaran K, Regional blood-brain barrier transport of cationized bovine serum albumin in awake rats. Am J Physiol 1991;261:R478-83
   PubMed Web of Science ®Google Scholar
• Wadhwani KC, Shimon-Hophy M, Rapoport SI. Enhanced permeabilities of cationized-bovine serum albumins at the blood-nerve and blood-brain barriers in awake rats. J Neurosci Res 1992;32:407-14
   PubMed Web of Science ®Google Scholar
• Agarwal A, Agrawal H, Tiwari S, Cationic ligand appended nanoconstructs: a prospective strategy for brain targeting. Int J Pharm 2011;421:189-201
   PubMed Web of Science ®Google Scholar
• Hsu MH, Su YC. Iron-oxide embedded solid lipid nanoparticles for magnetically controlled heating and drug delivery. Biomed Microdevices 2008;6:785-93
   Google Scholar
• Bareschino MA, Schettino C, Rossi A, Treatment of advanced non small cell lung cancer. J Thorac Dis 2011;3:122-33
   Google Scholar
• National cancer institute; general information about non-small cell lung cancer treatment. 2012. Available from: http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/healthprofessional [Last accessed 14 May 2012]
   Google Scholar
• Shi SJ, Zhong ZR, Liu J, Solid lipid nanoparticles loaded with anti-microRNA oligonucleotides (AMOs) for suppression of MicroRNA-21 functions in human lung cancer cells. Pharm Res 2012;29:97-109
   PubMed Web of Science ®Google Scholar
• Wan F, You J, Sun Y, Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro. Int J Pharm 2008;359:104-10
   PubMed Web of Science ®Google Scholar
• You J, Wan F, de Cui F, Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles. Int J Pharm 2007;343:270-6
   PubMed Web of Science ®Google Scholar
• Amoozgar Z, Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012;4:219-33
   PubMed Web of Science ®Google Scholar
• National cancer institute; general information about colon cancer. 2012. Available from: http://www.cancer.gov/cancertopics/pdq/treatment/colon/HealthProfessional/page1 [Last accessed 14 May 2012]
   Google Scholar
• Yassin AE, Anwer MK, Mowafy HA, Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. Int J Med Sci 2010;7:398-408
   PubMed Web of Science ®Google Scholar
• Minelli R, Serpe L, Pettazzoni P, Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells. Br J Pharmacol 2011;166:587-601
   Web of Science ®Google Scholar
• American cancer society; breast cancer. 2012. Available from: http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-treating-general-info [Last accessed 14 May 2012]
   Google Scholar
• Lu B, Xiong SB, Yang H, Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases. Eur J Pharm Sci 2006;28:86-95
   PubMed Web of Science ®Google Scholar
• Reddy LH, Vivek K, Bakshi N, Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation. Pharm Dev Technol 2006;11:167-77
   PubMed Web of Science ®Google Scholar
• Zhigaltsev IV, Winters G, Srinivasulu M, Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles. J Control Release 2010;144:332-40
   PubMed Web of Science ®Google Scholar
• Gong X, Moghaddam MJ, Sagnella SM, Lamellar crystalline self-assembly behaviour and solid lipid nanoparticles of a palmityl prodrug analogue of capecitabine–a chemotherapy agent. Colloids Surf B Biointerfaces 2011;85:349-59
   PubMed Web of Science ®Google Scholar
• Hrycushko BA, Gutierrez AN, Goins B, Radiobiological characterization of post-lumpectomy focal brachytherapy with lipid nanoparticle-carried radionuclides. Phys Med Biol 2011;56:703-19
   PubMed Web of Science ®Google Scholar
• Alvarez P, Marchal JA, Boulaiz H, 5-fluorouracil derivatives: a patent review. Expert Opin Ther Pat 2012;22:107-23
   PubMed Web of Science ®Google Scholar
• Venishetty VK, Komuravelli R, Kuncha M, Increased brain uptake of docetaxel and ketoconazole loaded folate grafted solid lipid nanoparticles. Nanomedicine 2012; In press
   Web of Science ®Google Scholar
• Kuo YC, Liang CT. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor. Biomaterials 2011;32:3340-50
   PubMed Web of Science ®Google Scholar
• Brioschi A, Zara GP, Calderoni S, Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug. Molecules 2008;13:230-54
   PubMed Web of Science ®Google Scholar
• Goppert TM, Müller RH. Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles. J Drug Target 2003;11:225-31
   PubMed Web of Science ®Google Scholar
• Mollinedo F, de la Iglesia-Vicente J, Gajate C, In vitro and in vivo selective antitumor activity of edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts. Clin Cancer Res 2010;16:2046-54
   PubMed Web of Science ®Google Scholar
• Estella-Hermoso de Mendoza A, Campanero MA, de la Iglesia-Vicente J, Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice. Clin Cancer Res 2009;15:858-64
   PubMed Web of Science ®Google Scholar
• American cancer society: Ovarian cancer. 2010. Available from: http://www.cancer.org/Cancer/OvarianCancer/DetailedGuide/ovarian-cancer [Last accessed 20 May 2012]
   Google Scholar
• Siddiqui A, Patwardhan GA, Liu YY, Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: in vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells. Int J Pharm 2010;400:251-9
   PubMed Web of Science ®Google Scholar
• Zhang P, Chen L, Zhang Z, Pharmacokinetics in rats and efficacy in murine ovarian cancer model for solid lipid nanoparticles loading docetaxel. J Nanosci Nanotechnol 2010;10:7541-4
   PubMed Web of Science ®Google Scholar
• Lee MK, Lim SJ, Kim CK. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 2007;28:2137-46
   PubMed Web of Science ®Google Scholar
• Sanjula B, Shah FM, Javed A, Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. J Drug Target 2009;17:249-56
   PubMed Web of Science ®Google Scholar
• Reddy LH, Adhikari JS, Dwarakanath BS, Tumoricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in Dalton's lymphoma bearing mice. AAPS J 2006;8:E254-62
   PubMed Web of Science ®Google Scholar
• Ma P, Dong X, Swadley CL, Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome pgp-mediated multiple drug resistance in leukemia. J Biomed Nanotechnol 2009;5:151-61
   PubMed Web of Science ®Google Scholar
• Pan X, Chen L, Liu S, Antitumor activity of G3139 lipid nanoparticles (LNPs). Mol Pharm 2009;6:211-20
   PubMedGoogle Scholar
• Bauman JA, Li SD, Yang A, Anti-tumor activity of splice-switching oligonucleotides. Nucleic Acids Res 2010;38:8348-56
   PubMed Web of Science ®Google Scholar
• de Jesus MB, Ferreira CV, de Paula E, Design of solid lipid nanoparticles for gene delivery into prostate cancer. J Control Release 2010;148:e89-90
   PubMed Web of Science ®Google Scholar
• French JT, Goins B, Saenz M, Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide. J Vasc Interv Radiol 2010;21:1271-9
   PubMed Web of Science ®Google Scholar
• Holpuch AS, Hummel GJ, Tong M, Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies. Pharm Res 2010;27:1224-36
   PubMed Web of Science ®Google Scholar
• Kohane DS, Langer R. Biocompatibility and drug delivery systems. Chem Sci 2010;1:441-6
   Web of Science ®Google Scholar
• Joshi MD, Müller RH. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 2009;71:161-72
   PubMed Web of Science ®Google Scholar
• Severino P, Andreani T, Macedo AS, Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J Drug Deliv 2012;2012:750891
   PubMedGoogle Scholar
• Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 2007;59:478-90
   PubMed Web of Science ®Google Scholar
• Fangueiro JF, Gonzalez-Mira E, Martins-Lopes P, A novel lipid nanocarrier for insulin delivery: production, characterization and. toxicity testing. Pharm Dev Technol 2011; published online 28 June 2011 p. 12
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Fu H, Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 2008;356:333-44
   PubMed Web of Science ®Google Scholar
• Rawat MK, Jain A, Singh S. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats. J Pharm Sci 2011;6:2406-7
   Google Scholar
• üWissing SA, Kayser O, Mller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004;56:1257-72
   PubMed Web of Science ®Google Scholar
• Smijs TG, Bouwstra JA. Focus on skin as a possible port of entry for solid nanoparticles and the toxicological impact. J Biomed Nanotechnol 2010;6:469-84
   PubMed Web of Science ®Google Scholar
• Spada G, Gavini E, Cossu M, Solid lipid nanoparticles with and without hydroxypropyl-beta-cyclodextrin: A comparative study of nanoparticles designed for colonic drug delivery. Nanotechnol 2012; published on line 6 Feb 2012; doi: doi:10.1088/0957-4484/23/9/095101
   PubMed Web of Science ®Google Scholar
• Estella-Hermoso de Mendoza A, Calvo P, Bishop A, Comparison of pharmacokinetic profiles of PM02734 loaded lipid nanoparticles and cyclodextrins: in vitro and in vivo characterization. J Biomed Nanotechnol 2012;8:723-8
   Google Scholar
• Feng L, Wu H, Ma P, Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo. Int J Nanomedicine 2011;6:2545-56
   PubMed Web of Science ®Google Scholar
• Lim S, Lee M, Kim C. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J Control Release 2004;100:53-61
   PubMed Web of Science ®Google Scholar
• Song H, Nie S, Yang X, Characterization and in vivo evaluation of novel lipid-chlorambucil nanospheres prepared using a mixture of emulsifiers for parenteral administration. Int J Nanomedicine 2010;5:933-42
   PubMed Web of Science ®Google Scholar
• Wang L, Liu Z, Liu D, Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Int J Pharm 2011;413:194-201
   PubMed Web of Science ®Google Scholar
• Piao H, Ouyang M, Xia D, In vitro–in vivo study of CoQ10-loaded lipid nanoparticles in comparison with nanocrystals. Int J Pharm 2011;419:255-9
   PubMed Web of Science ®Google Scholar
• Teskac K, Kristl J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm 2010;390:61-9
   PubMed Web of Science ®Google Scholar
• Lee P, Zhang R, Li V, Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulation. Int J Nanomedicine 2012;7:731-7
   PubMed Web of Science ®Google Scholar
• Dong X, Mattingly CA, Tseng M, Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization. Eur J Pharm Biopharm 2009;72:9-17
   PubMed Web of Science ®Google Scholar
• Oyewumi MO, Mumper RJ. Gadolinium-loaded nanoparticles engineered from microemulsion templates. Drug Dev Ind Pharm 2002;28:317-28
   PubMed Web of Science ®Google Scholar
• Gallarate M, Trotta M, Battaglia L, Cisplatin-loaded SLN produced by coacervation technique. J Drug Deliv Sci Tech 2010;20:343-7
   Web of Science ®Google Scholar
• Chirio D, Gallarate M, Peira E, Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique. J Microencapsul 2011;28:537-48
   PubMed Web of Science ®Google Scholar
• Battaglia L, Serpe L, Muntoni E, Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution. Nanomedicine 2011;6:1561-73
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Benoit J. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J Control Release 2006;112:208-13
   PubMed Web of Science ®Google Scholar
• Malzert-Fréon A, Vrignaud S, Saulnier P, Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agent. Int J Pharm 2006;320:157-64
   PubMed Web of Science ®Google Scholar
• Lacoeuille F, Hindre F, Moal F, In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. Int J Pharm 2007;344:143-9
   PubMedGoogle Scholar
• Yu YH, Kim E, Park DE, Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA. Eur J Pharm Biopharm 2012;80:268-73
   PubMed Web of Science ®Google Scholar
• Tian J, Pang X, Yu K, Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin. Pharmazie 2008;63:593-7
   PubMed Web of Science ®Google Scholar
• Ali H, Shirode AB, Sylvester PW, Preparation, characterization, and anticancer effects of simvastatin-tocotrienol lipid nanoparticles. Int J Pharm 2010;389:223-31
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Kanaujia P, Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surf B Biointerfaces 2011;88:483-9
   PubMed Web of Science ®Google Scholar
• Videira M, Almeida AJ, Fabra A. Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect. Nanomedicine 2011; published on line 27 December 2011; doi: 10.1016/j.nano.2011.12.007
   Web of Science ®Google Scholar
• Abuasal BS, Lucas C, Peyton B, Enhancement of intestinal permeability utilizing solid lipid nanoparticles increases gamma-tocotrienol oral bioavailability. Lipids 2012;47:461-9
   PubMed Web of Science ®Google Scholar
• Pandita D, Ahuja A, Velpandian T, Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique. Pharmazie 2009;64:301-10
   PubMed Web of Science ®Google Scholar
• Wang T, Wang N, Zhang Y, Solvent injection-lyophilization of tert-butyl alcohol/water cosolvent systems for the preparation of drug-loaded solid lipid nanoparticles. Colloids Surf B Biointerfaces 2010;79:254-61
   PubMed Web of Science ®Google Scholar